Connect with us

Hi, what are you looking for?

Jewish Business News


Beijing faces ‘very high’ risk of COVID-19 epidemic broke out from a food wholesale market

The market in Beijing is more than 20 times larger than Wuhan’s seafood market, where coronavirus was the first outbreak.  

After nearly two months with no new coronavirus infections, China has reported 79 new cases in Beijing over the past four days, the biggest infections since February.

The return of COVID-19’s risk in the Chinese capital, with a population of 21.5 million, ‘is very high,’ warned Chinese Vice Premier Sun Chunlan at a meeting on Sunday.

She said Xinfadi, the market at the center of the cluster, had a highly dense and mobile population and could, therefore, prompt the epidemic to spread. The market is more than 20 times larger than Wuhan’s seafood market, where coronavirus was the first outbreak.

Sun urged officials to implement ‘resolute’ and ‘decisive’ measures to stop a possible resurgence of the virus.

‘The risk of the epidemic spreading is very high, so we should take resolute and decisive measures,’ Xu Hejiang, a spokesman at the Beijing city government, instructed. Beijing has locked down at least 11 neighborhoods close to the infected market and launched a mass-testing program to screen those who have visited the market or live nearby.

Several districts in Beijing reinstated security checkpoints, ordered residents to be tested and closed schools on Monday in response to the unexpected resurgence of COVID-19.

At these uncertain times, China is trying to shake off the economic torpor of the virus, as the headquarters of many major corporations located in the city.


Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


Now Platika joins and elite club of $10 billion plus Israeli firms.